In a strategic move to reposition its focus on its core RNA delivery technology, Altamira Technologies has sold a majority stake in its subsidiary Altamira Medica AG to a Swiss private equity investor …
Read Full Story at source (may require registration)
- How to Sell a Small Business: A Starter Guide for Business Owners - February 3, 2025
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024